Hillstream BioPharma, Inc. announced the pricing of its initial public offering of 3,750,000 shares of the Company’s common stock at a public offering price of $4.00 per share for aggregate gross proceeds of $15,000,000 prior to deducting underwriting discounts, commissions, and other offering expenses.
January 11, 2022
· 4 min read
